Inhibrx Revenue 2020-2022 | INBX
Inhibrx revenue from 2020 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Inhibrx Annual Revenue
(Millions of US $) |
| 2021 |
$7 |
| 2020 |
$13 |
| 2019 |
$13 |
Inhibrx Quarterly Revenue
(Millions of US $) |
| 2022-03-31 |
$1 |
| 2021-12-31 |
$3 |
| 2021-09-30 |
$3 |
| 2021-06-30 |
$1 |
| 2021-03-31 |
$1 |
| 2020-12-31 |
$3 |
| 2020-09-30 |
$6 |
| 2020-06-30 |
$3 |
| 2020-03-31 |
$1 |
| 2019-12-31 |
|
| 2019-09-30 |
$1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.527B |
$0.007B |
|
Inhibrx Inc. is a clinical-stage biotechnology company. The company's pipeline is focused on oncology and orphan diseases. Inhibrx Inc. is based in SAN DIEGO.
|
